Related Experiment Video
Updated: Nov 6, 2025

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
Published on: June 2, 2015
Cerebral Venous Thrombosis Associated with COVID-19 Infection: An Observational, Multicenter Study
Sajid Hameed1, Mohammad Wasay1, Bashir A Soomro2
1Department of Medicine, Aga Khan University, Karachi, Pakistan.
Insights
Cerebral venous thrombosis (CVT) is more common in males with COVID-19. While mortality is high, survivors of COVID-19-related CVT often experience good neurological recovery.
Area of Science:
- Neurology
- Infectious Diseases
- Vascular Medicine
Background:
- Coronavirus disease 2019 (COVID-19) is associated with hypercoagulability and thromboembolism.
- Cerebral venous thrombosis (CVT) has been reported in COVID-19 patients.
Purpose of the Study:
- To identify risk factors for CVT in COVID-19 patients.
- To describe the presentation and outcomes of CVT in COVID-19 patients.
Main Methods:
- Multicenter, multinational observational study.
- Included adult patients (>18 years) with symptomatic CVT and recent COVID-19 infection.
Main Results:
- Twenty male patients (mean age 42.4 years) with CVT and COVID-19 were included.
- Headache and seizures were common symptoms; CVT presented early in 65% of cases.
- Superior sagittal sinus thrombosis was most common; elevated D-dimer and inflammatory markers were frequent. Mortality was 20%, but survivors had good functional outcomes.
Conclusions:
- COVID-19-related CVT affects males more frequently and at older ages than non-COVID-19 CVT.
- Suspect CVT in COVID-19 patients with headache or seizures.
- Despite high mortality, survivors of COVID-19-related CVT show good neurological recovery.
Background And Purpose:
Coronavirus disease 2019 (CO-VID-19) has an increased propensity for systemic hypercoagulability and thromboembolism. An association with cerebrovascular diseases, especially cerebral venous thrombosis (CVT), has been reported among these patients. The objective of the present study was to identify risk factors for CVT as well as its presentation and outcome in COVID-19 patients.
Methods:
This is a multicenter and multinational observational study. Ten centers in 4 countries (Pakistan, Egypt, Singapore, and the United Arab Emirates) participated in this study. The study included patients (aged >18 years) with symptomatic CVT and recent COVID-19 infection.
Results:
Twenty patients (70% men) were included. Their mean age was 42.4 years, with a male-to-female ratio of 2.3:1. Headache (85%) and seizures (65%) were the common presenting symptoms, with a mean admission Glasgow Coma Scale (GCS) score of 13. CVT was the presenting feature in 13 cases (65%), while 7 patients (35%) developed CVT while being treated for COVID-19 infection. Respiratory symptoms were absent in 45% of the patients. The most common imaging finding was infarction (65%), followed by hemorrhage (20%). The superior sagittal sinus (65%) was the most common site of thrombosis. Acute inflammatory markers were raised, including elevated serum D-dimer (87.5%), erythrocyte sedimentation rate (69%), and C-reactive protein (47%) levels. Homocysteine was elevated in half of the tested cases. The mortality rate was 20% (4 patients). A good functional outcome was seen in the surviving patients, with a mean modified Rankin Scale score at discharge of 1.3. Nine patients (45%) had a modified Rankin Scale score of 0-1 at discharge.
Conclusion:
COVID-19-related CVT is more common among males at older ages when compared to previously reported non-COVID-19-related CVT cases. CVT should be suspected in COVID-19 patients presenting with headache or seizures. Mortality is high, but functional neurological outcome is good among survivors.
More Related Videos
Related Concept Videos
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis I: Introduction
Venous Thrombosis III: Interprofessional Care
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis IV: Nursing Management

